"Vascular age" is advanced in children with atherosclerosis-promoting risk factors

Joseph Le1, Danna Zhang, Spencer Menees

  • 1School of Medicine and the Department of Mathematics and Statistics, University of Missouri-Kansas City; and the Department of Pediatrics, Children's Mercy Hospital, Kansas City, MO, USA.

Insights

Obese children and those with familial dyslipidemia show advanced vascular age, indicating early atherosclerosis. High triglycerides in obese children are linked to this accelerated vascular aging.

Area of Science:

  • Pediatric Cardiology
  • Vascular Biology
  • Cardiovascular Risk Factors

Background:

  • Childhood obesity and familial dyslipidemia are linked to accelerated atherosclerosis.
  • Carotid artery intima-media thickness (CIMT) is a marker for subclinical atherosclerosis.
  • Limited normative CIMT data for children necessitates using adult comparisons.

Purpose of the Study:

  • To determine if children with obesity or familial dyslipidemia exhibit increased CIMT, comparable to adults.
  • To assess the prevalence of advanced "vascular age" (VA) in these pediatric populations.

Main Methods:

  • Carotid artery ultrasound was performed on 70 children (ages 6-19) with risk factors like dyslipidemia, hypertension, insulin resistance, or smoke exposure.
  • Advanced VA was defined as CIMT at or above the 25th percentile for 45-year-old adults.
  • Body mass index (BMI) and other risk factors were evaluated.

Main Results:

  • 57% of children had BMI at or above the 95th percentile.
  • 75% of obese children and 73% of familial dyslipidemic children demonstrated advanced VA.
  • Obese children with high fasting triglycerides were more likely to have advanced VA.

Conclusions:

  • Advanced vascular age is prevalent and comparable in obese children with risk factors and those with familial dyslipidemia.
  • Obese children with high triglyceride levels show a higher likelihood of advanced vascular age.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...